iNtRON Biotechnology Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Alek Yoon
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 24.3yrs |
| CEO ownership | 14.8% |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
We Think iNtRON Biotechnology (KOSDAQ:048530) Can Stay On Top Of Its Debt
May 03
We Believe iNtRON Biotechnology's (KOSDAQ:048530) Earnings Are A Poor Guide For Its Profitability
Mar 24Does iNtRON Biotechnology's (KOSDAQ:048530) Share Price Gain of 81% Match Its Business Performance?
Feb 28iNtRON Biotechnology, Inc.'s (KOSDAQ:048530) Stock Is Going Strong: Is the Market Following Fundamentals?
Jan 31
iNtRON Biotechnology (KOSDAQ:048530) Has A Rock Solid Balance Sheet
Jan 05What iNtRON Biotechnology, Inc.'s (KOSDAQ:048530) 26% Share Price Gain Is Not Telling You
Dec 10iNtRON Biotechnology (KOSDAQ:048530) Share Prices Have Dropped 49% In The Last Five Years
Nov 26CEO
Alek Yoon (54 yo)
24.3yrs
Tenure
Mr. Seong-Jun Yoon, also known as Alek, has been the Chief Executive Officer of iNtRON Biotechnology, Inc. since 2002 and serves as its President. Mr. Yoon served as the Chief Executive Officer of iNtRON B...